The next wave of recombinant and synthetic anticancer vaccines
- 31 December 1995
- journal article
- review article
- Published by Elsevier in Seminars in Cancer Biology
- Vol. 6 (6) , 337-347
- https://doi.org/10.1016/1044-579x(95)90003-9
Abstract
No abstract availableKeywords
This publication has 121 references indexed in Scilit:
- From defined human tumor antigens to effective immunization?Immunology Today, 1995
- Immunization by Direct DNA Inoculation Induces Rejection of Tumor Cell ChallengeHuman Gene Therapy, 1995
- Mutant Oncopeptide Immunization Induces CTL Specifically Lysing Tumor Cells Endogenously Expressing the Corresponding Intact Mutant p53Hybridoma, 1995
- MHC: orchestrating the immune responseImmunology Today, 1995
- Cytokine gene transfer in tumor inhibition and tumor therapy: where are we now?Immunology Today, 1994
- MHC-dependent antigen processing and peptide presentation: Providing ligands for T lymphocyte activationCell, 1994
- Antitumor Activity and Immune Responses Induced by a Recombinant Carcinoembryonic Antigen-Vaccinia Virus VaccineJNCI Journal of the National Cancer Institute, 1992
- A recombinant vaccinia virus expressing human carcinoembryonic antigen (CEA)International Journal of Cancer, 1991
- Actin filaments and the growth, movement, and spread of the intracellular bacterial parasite, Listeria monocytogenes.The Journal of cell biology, 1989
- Use of Tumor-Infiltrating Lymphocytes and Interleukin-2 in the Immunotherapy of Patients with Metastatic MelanomaNew England Journal of Medicine, 1988